<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031013</url>
  </required_header>
  <id_info>
    <org_study_id>021ACR-EMTDialyse</org_study_id>
    <nct_id>NCT05031013</nct_id>
  </id_info>
  <brief_title>Trace Elements Concentration in Dialysis</brief_title>
  <acronym>EMTDialyse</acronym>
  <official_title>Trace Elements Concentration in Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>laboratoire ILM - Université Lyon 1 CNRS, UMR 5306 UCBL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MEXBrain 13 avenue Albert Einstein 69100 Villeurbanne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In hemodialysis population the study team finds high concentrations of toxic trace elements&#xD;
      (2 times higher than the general population for cadmium 4 to 13 times for lead). Several&#xD;
      recent studies suggest a role of chronic exposure to cadmium in the loss of residual renal&#xD;
      function, osteoporosis, graft failure, arteriosclerosis, as well as in excess cardiovascular&#xD;
      mortality.&#xD;
&#xD;
      Moreover, in hemodialysis population, a deficit of certain essential trace elements&#xD;
      (manganese, selenium, zinc) is observed. For example, in the population undergoing chronic&#xD;
      hemodialysis, a zinc deficiency is found in 40 to 78% of cases. Zinc is a cofactor of more&#xD;
      than 70 enzymes.&#xD;
&#xD;
      In this observational cohort, the study team seeks to understand the impact of HD and HDF on&#xD;
      the serum concentrations of heavy metals and also oligometals, by studying their&#xD;
      concentrations in the dialysate during dialysis sessions by inductive coupled plasma&#xD;
      mass-spectrometry (ICP-MS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective: Evaluate the trace element concentration (heavy metals Cd and Pb and&#xD;
      oligometals: Fe, Zn, Cu, Mn and also Se) in the dialysate before and during dialysis session.&#xD;
      By studying the variation in concentration between the initial concentration of trace element&#xD;
      in the dialysis fluid and the final concentration after membrane in the dialysate (waste&#xD;
      pipe).&#xD;
&#xD;
      Method : Prospective study, in dialysis population, inclusion period will be from September&#xD;
      1, 2021 to January 31, 2022, in Ambroise Paré hospital, Paris, France. Duration of follow-up&#xD;
      will be 1 day.&#xD;
&#xD;
      Dialysate samples will be taken in the venous injection site before connecting the patient,&#xD;
      at 0 and 10 minutes after disinfection.&#xD;
&#xD;
      After connecting the patients, post-membrane dialysis sample (waste pipe) will be taken at&#xD;
      30, 60, 120 and 180minutes. Trace element dosage will be done by ICP-MS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Trace elements concentration</measure>
    <time_frame>5 months</time_frame>
    <description>Trace elements concentration in the dialysate during dialysis sessions by inductive coupled plasma mass-spectrometry (ICP-MS).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Dialysis</condition>
  <arm_group>
    <arm_group_label>Dialysis patients</arm_group_label>
    <description>Dialysis patients</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      dialysat samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Dialysis patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 18;&#xD;
&#xD;
          -  End-stage chronic renal failure in chronic dialysis;&#xD;
&#xD;
          -  Duration of dialysis session ≥3h;&#xD;
&#xD;
          -  Vascular approach: arteriovenous fistula;&#xD;
&#xD;
          -  Affiliation to a social security scheme or entitled.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Opposition to participate to the study;&#xD;
&#xD;
          -  Daily dialysis;&#xD;
&#xD;
          -  Duration of dialysis session &lt; 3h and &gt; 8h;&#xD;
&#xD;
          -  Vascular approach: venous catheter; Weekly dialysis session ≤3; Patient under french&#xD;
             AME health system.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aymeric Couturier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service néphrologie et dialyse, hôpital Ambroise Paré</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aymeric Couturier, MD</last_name>
    <phone>+33171167685</phone>
    <email>aymeric.couturier@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nephrology Department and Dialysis Unit</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network. Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study. Am J Kidney Dis. 2017 Nov;70(5):696-704. doi: 10.1053/j.ajkd.2017.06.029. Epub 2017 Aug 31.</citation>
    <PMID>28838766</PMID>
  </reference>
  <reference>
    <citation>Prodanchuk M, Makarov O, Pisarev E, Sheiman B, Kulyzkiy M. Disturbances of trace element metabolism in ESRD patients receiving hemodialysis and hemodiafiltration. Cent European J Urol. 2014;66(4):472-6. doi: 10.5173/ceju.2013.04.art23. Epub 2014 Jan 27.</citation>
    <PMID>24757548</PMID>
  </reference>
  <reference>
    <citation>Orr SE, Bridges CC. Chronic Kidney Disease and Exposure to Nephrotoxic Metals. Int J Mol Sci. 2017 May 12;18(5). pii: E1039. doi: 10.3390/ijms18051039. Review.</citation>
    <PMID>28498320</PMID>
  </reference>
  <reference>
    <citation>Messner B, Knoflach M, Seubert A, Ritsch A, Pfaller K, Henderson B, Shen YH, Zeller I, Willeit J, Laufer G, Wick G, Kiechl S, Bernhard D. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1392-8. doi: 10.1161/ATVBAHA.109.190082. Epub 2009 Jun 25.</citation>
    <PMID>19556524</PMID>
  </reference>
  <reference>
    <citation>Lee CC, Weng CH, Huang WH, Yen TH, Lin JL, Lin-Tan DT, Chen KH, Hsu CW. Association Between Blood Cadmium Levels and Mortality in Peritoneal Dialysis. Medicine (Baltimore). 2016 May;95(19):e3717. doi: 10.1097/MD.0000000000003717.</citation>
    <PMID>27175714</PMID>
  </reference>
  <reference>
    <citation>Sotomayor CG, Groothof D, Vodegel JJ, Eisenga MF, Knobbe TJ, IJmker J, Lammerts RGM, de Borst MH, Berger SP, Nolte IM, Rodrigo R, Slart RHJA, Navis GJ, Touw DJ, Bakker SJL. Plasma cadmium is associated with increased risk of long-term kidney graft failure. Kidney Int. 2021 May;99(5):1213-1224. doi: 10.1016/j.kint.2020.08.027. Epub 2020 Sep 14.</citation>
    <PMID>32941876</PMID>
  </reference>
  <reference>
    <citation>Larsson SC, Wolk A. Urinary cadmium and mortality from all causes, cancer and cardiovascular disease in the general population: systematic review and meta-analysis of cohort studies. Int J Epidemiol. 2016 Jun;45(3):782-91. doi: 10.1093/ije/dyv086. Epub 2015 May 20. Review.</citation>
    <PMID>25997435</PMID>
  </reference>
  <reference>
    <citation>Satarug S, C Gobe G, A Vesey D, Phelps KR. Cadmium and Lead Exposure, Nephrotoxicity, and Mortality. Toxics. 2020 Oct 13;8(4). pii: E86. doi: 10.3390/toxics8040086. Review.</citation>
    <PMID>33066165</PMID>
  </reference>
  <reference>
    <citation>Roozbeh J, Sharifian M, Sagheb MM, Shabani S, Hamidian Jahromi A, Afshariani R, Pakfetrat M, Salehi O. Comment on: does zinc supplementation affect inflammatory markers in hemodialysis patients? Ren Fail. 2011;33(4):466-7. doi: 10.3109/0886022X.2011.568144.</citation>
    <PMID>21529280</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dialysis</keyword>
  <keyword>trace elements concentration</keyword>
  <keyword>cadmium</keyword>
  <keyword>lead</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

